期刊文献+

选择性醛甾酮拮抗药在高血压治疗中的应用 被引量:9

Using selective aldosterone antagonist in treatment of hypertension
下载PDF
导出
摘要 醛甾(固)酮与其受体结合后通过增加水钠潴留加重高血压。醛甾酮拮抗药分为选择性和非选择性2 大类。醛甾酮受体拮抗药不仅有助于降低血压,而且可减少醛甾酮对心血管系统的不利作用,减少心室肥厚和心血管事件的发生率。 The combination of aldosterone and its receptor leading to increase of sodium and water retention aggravate hypertension. Aldosterone receptor antagonist may divide to two types: selective and nonselective, not only help to reduce blood pressure, but also decrease the adverse cardiac-vascular effects of aldosterone, cardiac venticular hypertrophy and occurrence of cardiac-vascular events.
作者 黄震华
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第2期136-139,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 醛甾酮拮抗药 受体 醛甾酮 高血压 肾素-血管紧张肽系统 螺内酯 依普利酮 aldosterone antagonists receptor, aldosterone hypertension renin-angiotensin system spironolactone eplerenone
  • 相关文献

参考文献21

  • 1ROCHA R,WILLAMS GH.Rationale for the use of aldosterone antagonists in congestive heart failure[J].Drugs,2002,62(5):723-731.
  • 2BLACK HR.Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin Ⅱ receptor blockers in hypertension management:a review of mechanistic and clinical data[J].Am Heart J,2004,147(4):564-572.
  • 3BHARGAVA A,FULLERTON MJ,MYLES K,et al.The serumand glucocorticoid-induced kinase is a physiological mediator of aldosterone action[J].Endocrinology,2001,142(4):1587-1594.
  • 4ROCHA R,STIER CT,KIFOR I,et al.Aldosterone:a mediator of myocardial necrosis and renal arteriopathy[J].Endocrinology,2000,141 (10):3871-3878.
  • 5FARQUHARSON CA,STRUTHERS AD.Spironolactone increases nitric oxide bioactivity,improves endothelial vasodilator dysfunction,and suppresses vascular angiotensin Ⅰ / angiotensin Ⅱ conversion in patients with chronic heart failure[J].Circulation,2000,101 (6):594-597.
  • 6STRUTHERS AD.Aldosterone:cardiovascular assault[J].Am Heart J,2002,144(5 Suppl):S2-S7.
  • 7STOWASSER M.New perspectives on the role of aldosterone excess in cardiovascular disease[J].Clin Exp Pharmacol Physiol,2001,28(10):783-791.
  • 8SCHLAICH MP,SCHOBEL HP,HILGERS K,et al.Impact of aldosterone on left ventricular structure and function in young normotensive and mild hypertensive subjects[J].Am J Cardiol,2000,85(10):1199-1206.
  • 9TSUTAMOTO T,WADA A,MAEDA K,et al.Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure[J].J Am Coll Cardiol,2001,37(5):1228-1233.
  • 10ROCHA R,MARTIN-BERGER CL,YANG P,et al.Selective aldosterone blockade prevents angiotensin Ⅱ/ salt induced vascular inflammation in the rat heart[J].Endocrinology,2002,143 (12):4828-4836.

同被引文献64

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部